drugset / Trial / NCT00449423

Metabolic Modulation as Treatment in Acute Heart Failure

NCT00449423 ↗

Phase 2 Terminated 32 enrolled University of Aarhus
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to evaluate whether metabolic modulation improves hemodynamics and outcome in acute heart failure

Timeline

Start
2007-03
Primary completion
—
Completion
2007-10

Outcome

Outcome not reported

Stopped (Enrollment): “due to slow recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Acipimox Small molecule — —

Indications